GlassScriptPhysician profile
Peter S Liu
NPI 1952540072
$1,973.18
in general payments reported to CMS, 2019-2025
24 companies · $247 in 2025
The $247 reported for 2025 was more than what a typical Surgical provider received nationally (typical 2025 total: $146).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $206 · 2022: $372 · 2023: $309 · 2024: $839 · 2025: $247.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,395.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,395.04 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $544.35 | 2022-2025 | Monterey Al, Canyon Retractor Systems, Xia 3 |
| Highridge Medical LLC | $230.04 | 2024 | Biomet Spinalpak Non-Invasive Spine Fusion Stimulator System, Biomet Ebi Bone Healing System |
| Scilex Pharmaceuticals INC. | $222.03 | 2021-2023 | Ztlido |
| Djo, LLC | $150.12 | 2023-2024 | Cmf |
| Biotronik Nro, INC. | $109.38 | 2024 | Prospera |
| Nuvasive, INC. | $81.16 | 2021-2022 | |
| Si-Bone, INC. | $76.82 | 2022-2024 | |
| Acera Surgical, INC. | $74.68 | 2025 | Restrata Wound Matrix |
| Zimmer Biomet Holdings, INC. | $74.24 | 2021 | |
| Augmedics INC. | $59.02 | 2025 | Xvision |
| Medtronic, INC. | $47.49 | 2023-2024 | Plasmablade(Tm), Aquamantys(Tm) |
| Integra Lifesciences Corporation | $38.09 | 2024 | Duraseal Exact Spinal Sealant System, Codman Certas, Codman Hakim |
| Boston Scientific Corporation | $36.22 | 2021-2024 | |
| Ibsa Pharma INC. | $30.31 | 2023 | Tirosint, Licart |
| Xtant Medical INC | $30.00 | 2023 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mml US, INC. | $28.62 | 2025 | Reactiv8 |
| Sanara Medtech INC. | $26.26 | 2025 | Celleraterx |
| Nalu Medical, INC. | $23.16 | 2024 | Nalu Neurostimulation System |
| Vertex Pharmaceuticals Incorporated | $16.69 | 2025 | |
| Spr Therapeutics, INC | $16.13 | 2025 | Sprint Pns System |
| Saluda Medical Americas, INC. | $15.86 | 2023 | Evoke Scs |
| Ultragenyx Pharmaceutical INC. | $14.94 | 2021 | |
| Averitas Pharma INC. | $14.54 | 2024 | Qutenza |
| Relievant Medsystems, INC. | $13.03 | 2023 | Intracept |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Peter Liu listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.